ArticleJournal of experimental orthopaedics2026
Short-term patient-reported outcomes following rectus femoris versus quadriceps tendon and hamstring tendon autografts for ACL reconstruction with concomitant anterolateral procedure: A prospective comparative study.
Article in Journal of experimental orthopaedics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To compare short-term patient-reported outcomes following anterior cruciate ligament reconstruction (ACLR) with concomitant anterolateral procedure, using rectus femoris (RF), quadriceps tendon (QT) and hamstring tendons (HS) autografts. It was hypothesized that short-term patient-reported outcomes would not differ significantly across graft strategies at 1-year follow-up. Methods: A prospective comparative non-randomized study was conducted, including 90 consecutive patients undergoing primary ACLR between May 2022 and June 2023 (30 per group). Outcomes were assessed at a median follow-up of 15.0 months (range: 12-22) using the Knee injury and Osteoarthritis Outcome Score (KOOS) Pain and Quality of Life (QoL) subscales, EuroQOL 5-dimensions 5-level index (EQ-5D-5L), global satisfaction (0-100) and the Patient and Observer Scar Assessment Scale (POSAS). Continuous variables were compared using one-way analysis of variance with Bonferroni-corrected post hoc comparisons and categorical variables using Results: Of the 90 consecutive patients initially included, one patient in the RF group was excluded following graft failure and revision surgery prior to outcome assessment, leaving 89 patients available for analysis. Mean global satisfaction was 86.5 ± 10.9, KOOS Pain 89.1 ± 13.2, KOOS QoL 71.4 ± 22.2 and EQ-5D-5L Index 0.85 ± 0.15. No statistically significant differences were observed between graft types in KOOS QoL ( Conclusion: No statistically significant differences in short-term patient-reported outcomes were observed among RF, QT and HS autografts at 1-year follow-up. Graft strategy was not associated with differences in short-term postoperative patient-reported outcomes within the available sample. Level of Evidence: Level III.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.